𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma

✍ Scribed by Mulder, Nanno H.; Sleijfer, Dirk Th.; Smit, Jitty M.; de Vries, Elisabeth G.E.; Willemse, Pax H.B.; Schraffordt Koops, Heimen


Book ID
122943933
Publisher
Elsevier Science
Year
1986
Weight
294 KB
Volume
22
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Phase II study: The combination DTIC, BC
✍ Creagan, E. T. ;Schutt, A. J. ;Long, H. J. ;Green, S. J. πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

Thirty patients with disseminated malignant melanoma received the combination DTIC, BCNU, actinomycin D, and vincristine. The objective response rate was 17 percent concornitant with moderate-to-severe nausea and vomiting in 80 percent of patients. Hematologic toxicity was transient. In the dose and